NEW YORK (GenomeWeb News) – French molecular diagnostics company Genomic Vision today announced the launch of its initial public offering.

It plans to offer about 1.3 million shares of its stock at an expected price range of between €13.5 ($18.61) and €16.5 per share. At the midpoint of the range, the IPO is anticipated to raise about €20 million ($27.6 million), Genomic Vision said. The company plans to list its shares on Euronext Paris.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Nature News reports that early users of Oxford Nanopore's hand-held MinIon are giddy about the technology and its uses. 

In Cell this week: Leukemia-like disease in soft-shell clams, mNET-seq method for profiling growing transcrips, and more.

After seeing Rich's image of the DNA double helix structure in 1973, James Watson called Rich and told him that it was the first time in 20 years he'd had a good night's sleep.

In PNAS this week: genomic study of group B Streptococcus evolution, selection on the X chromosome in great apes, and more.